Disseminated Nocardiosis with Pulmonary Fungus and Secondary Epilepsy: A Case Report

Figures & data

Figure 1 Chest CT images of the patient. (A) Chest CT on December 27, 2021. (B) Chest CT imaging on December 29, 2021.

Table 1 Pathogenic Microorganism Identified in a Blood Sample

Type	Genus			Species
	Name	Relative Abundance	Sequence Number	Name	Identify Confidence	Sequence Number
G+	Nocardia	8.6%	210	Nocardia farcinica	99%	187

Table 2 Nocardia Susceptibility Results by the Kirby-Bauer Test

Antibiotic	K-B (mm)	Breakpoint (mm)	Interpratation
Amikacin	23	17–14	S
Imipenem	35	23–19	S
Linezolid	33	23–20	S
TMP-SMX	28	16–10	S

Abbreviations: S, susceptible; K-B, Kirby-Bauer test; TMP-SMX, trimethoprim-sulfamethoxazole.

Figure 2 Brain MRI images of the patient. (A) Brain MRI on December 30, 2021.

Table 3 Pathogenic Microorganism Identified in BALF

Type	Genus			Species
	Name	Relative Abundance	Sequence Number	Name	Identify Confidence	Sequence Number
G+	Nocardia	32.8%	378	Nocardia farcinica	99%	324

Figure 3 Chest CT images of the patient. (A) Chest CT on January 10, 2022. (B) Chest CT on January 17, 2022. (C) Chest CT on February 6, 2022. (D) Chest CT on April 16, 2022.

Figure 4 Brain MRI images of the patient. (A) Brain MRI on January 25, 2022. (B) Brain MRI on April 16, 2022.